Administration of Allogenic of Red Blood Cells Loaded L-Asparaginase in Acute Lymphoblastic Leukemia Relapse.
Phase of Trial: Phase I/II
Latest Information Update: 10 Jan 2012
At a glance
- Drugs ERY-ASP (Primary) ; Asparaginase
- Indications Acute lymphoblastic leukaemia
- Focus Pharmacodynamics
- Sponsors ERYtech Pharma
- 10 Jan 2012 Actual end date (1 Mar 2009 ) added as reported by ClinicalTrials.gov.
- 10 Jan 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 01 Apr 2011 Results published in the British Journal of Haematology.